Probiotics and Infections in Conscripts in Military Service
This study is ongoing, but not recruiting participants.
Sponsor:
Helsinki University Central Hospital
Collaborators:
Helsinki University
Finnish Defense Forces
National Institute for Health and Welfare, Finland
Information provided by (Responsible Party):
Anne pitkäranta, Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT01651195
First received: July 24, 2012
Last updated: November 14, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the effect of regular consumption of probiotic tablets in preventing illnesses in Finnish healthy adults attending military service.
| Condition | Intervention | Phase |
|---|---|---|
|
Respiratory Tract Infections Gastrointestinal Diseases Asthma Exacerbations |
Dietary Supplement: Probiotic Other: Placebo |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Primary Purpose: Prevention |
Resource links provided by NLM:
Further study details as provided by Helsinki University Central Hospital:
| Estimated Enrollment: | 900 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | January 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Probiotic tablet | Dietary Supplement: Probiotic |
| Placebo Comparator: Placebo tablet | Other: Placebo |
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Healthy adults attending military service in July 2012 and healthy adults attending reserve office school in October 2012
Exclusion Criteria:
- Regular use of oral corticosteroids
- Regular consumption (over 3 times a week) of probiotic bacteria containing products 3 weeks before intervention
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01651195
Locations
| Finland | |
| The Finnish Defence Forces | |
| Hamina, Finland | |
| The Finnish Defence Forces | |
| Upinniemi, Finland | |
Sponsors and Collaborators
Helsinki University Central Hospital
Helsinki University
Finnish Defense Forces
National Institute for Health and Welfare, Finland
More Information
No publications provided
| Responsible Party: | Anne pitkäranta, Professor/Chief Physician at Hospital District of Helsinki and Uusimaa, Helsinki University Central Hospital |
| ClinicalTrials.gov Identifier: | NCT01651195 History of Changes |
| Other Study ID Numbers: | 189/13/03/00/11 |
| Study First Received: | July 24, 2012 |
| Last Updated: | November 14, 2012 |
| Health Authority: | Finland: Ethics Committee |
Additional relevant MeSH terms:
|
Gastrointestinal Diseases Digestive System Diseases Respiratory Tract Infections Infection Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 22, 2013